This Pill Can Stop the Spread of HIV. Can Doctors Get It Into the Right Hands?

ANTI-HIV agents; DRUG accessibility; EMTRICITABINE-tenofovir (Drug); HIV infection transmission -- Prevention; WORLD AIDS day; CENTERS for Disease Control & Prevention (U.S.); WORLD Health Organization; MEDICAL research -- United States

The article discusses the World AIDS Day event in relation to U.S. medical research which indicates that providing PrEP (pre-exposure prophylaxis) drugs such as Truvada to men and transgender women who are high risk of contracting HIV dropped their rates of HIV infection. Other sexually transmitted diseases are mentioned, along with the efforts of the U.S. Centers for Disease Control and Prevention and the World Health Organization to make PrEP drugs available to consumers.